Three-quarters of life sciences executives believe their industry is doing a decent job of managing revenue, yet 69% believe their industry is losing billions of dollars due to issues like incorrect or ineffective pricing and quoting. What can executives do to optimize their revenue?

Hear from our industry experts as they present key insight from the 2023 State of Revenue Report – the fifth annual survey of executives who are responsible for optimizing revenue and ensuring compliance at large pharmaceutical and medical technology companies. Get a look at how revenue management teams are evolving to capitalize on new opportunities and overcome the macroeconomic trends that make revenue optimization so difficult.

Topics covered include:

• The market and innovation trends directly impacting life sciences organizations
• Reducing the impact of staffing issues on revenue management programs
• Leveraging innovative technologies to improve data and analytics capabilities
• Current challenges with ensuring compliance